- A G Dalgleish
- Professor of oncology Division of Oncology, Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London SW17 0RE
EDITOR,—It is easy to sympathise with some of the points on both sides of the argument over whether chemotherapy should be given for solid tumours.1 The nihilistic approach promulgated by G M Mead, however, would lead to no advances in treatment being made. As Mead points out, treatments that might benefit only a small percentage of patients will be sought by most patients—though not by their doctors, as pointed out by Slevin et al.2 The dramatic improvement in …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012